Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)

NCT00543387 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer, Neoplasms, Tumors

Interventions

DRUG: MK-5108
DRUG: docetaxel

Sponsor

Merck Sharp & Dohme LLC